Episode Details

Wall Street’s hype masks real trouble for Insteel, Neogen, and Fiserv—three companies where slowing growth, shrinking profits, and poor capital returns signal deeper problems than the market’s valuations suggest. Insteel’s flat revenue and collapsing cash flow margins show a competitive squeeze, Neogen’s declining sales and unprofitable operations hint at flawed strategy, and Fiserv’s lagging sales and low return on equity reveal misallocated capital. Don’t let the buzz fool you—these giants are struggling beneath the surface, and investors need to dig deeper before betting on their future.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/0503e912d07f60cf